Original Research

Published on 09 Apr 2024

Protective effect of oxytocin on vincristine-induced gastrointestinal dysmotility in mice

in Gastrointestinal and Hepatic Pharmacology

Shuang Li
Yao Shi
Jianchun Zhu
Jingxin Li
Shuanglian Wang
Chuanyong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1270612

1,352 views
3 citations

Original Research

Published on 09 Apr 2024

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients

in Gastrointestinal and Hepatic Pharmacology

Meng Sun
Jingyi Ju
Hongzhen Xu
Mengqi Luo
Zhaoyang Li
Yufang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360835

1,246 views

Systematic Review

Published on 05 Apr 2024

Efficacy and safety of low-dose esketamine for painless gastrointestinal endoscopy in adults: a systematic evaluation and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Juan Deng
Yun-Feng Yu
Zheng-Guo Tang
Hua-Juan Lei
Chuan-Chuan Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364546

1,443 views
1 citation

Review

Published on 28 Mar 2024

Understanding the action mechanisms of metformin in the gastrointestinal tract

in Gastrointestinal and Hepatic Pharmacology

Meihui Cheng
Lili Ren
Xianxian Jia
Jianwei Wang
Bin Cong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347047

8,398 views
3 citations

Brief Research Report

Published on 27 Mar 2024

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications

in Gastrointestinal and Hepatic Pharmacology

Sepideh Mehravar
Gabriela S. Leite
Mark Pimentel
Ali Rezaie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376656

713 views

Original Research

Published on 26 Mar 2024

The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status

in Gastrointestinal and Hepatic Pharmacology

Karla Vagnerová
Tomáš Hudcovic
Martin Vodička
Peter Ergang
Petra Klusoňová
Petra Petr Hermanová
Dagmar Šrůtková
Jiří Pácha

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341333

1,502 views

Original Research

Published on 26 Mar 2024

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity

in Gastrointestinal and Hepatic Pharmacology

Yuping Yang
Weinan Yuan
Kun He
Chuangzhen Lin
Shenshen Du
Yanqi Kou
Biao Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366479

1,783 views
1 citation

Review

Published on 21 Mar 2024

Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives

in Gastrointestinal and Hepatic Pharmacology

Qingyi Mao
Beibei Lin
Wenluo Zhang
Yu Zhang
Yu Zhang
Qian Cao
Mengque Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371574

4,373 views
3 citations

Original Research

Published on 15 Mar 2024

Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Jie Lin
Huaijuan Guo
Hanjiao Qin
Xuewen Zhang
Jiyao Sheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1374988

2,096 views

Correction

Published on 15 Mar 2024

Corrigendum: Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats

in Gastrointestinal and Hepatic Pharmacology

Wanyu Chen
Lu Liao
Zitong Huang
Yulin Lu
Yukang Lin
Ying Pei
Shulin Yi
Chen Huang
Hongying Cao
Bo Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394753

630 views

Systematic Review

Published on 14 Mar 2024

Effectiveness of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Zhuo Wang
Han-Shuo Hu
Li-Mei Zhao
Yu Li
Xiao-Dong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1324848

1,650 views

Original Research

Published on 07 Mar 2024

Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1

in Gastrointestinal and Hepatic Pharmacology

Chaoyuan Huang
Qiuhong Yong
Yihui Lu
Lu Wang
Yiyuan Zheng
Lina Zhao
Peiwu Li
Chong Peng
Wei Jia
Fengbin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1335814

2,741 views
4 citations

Original Research

Published on 01 Mar 2024

The effects of Massa Medicata Fermentata on the digestive function and intestinal flora of mice with functional dyspepsia

in Gastrointestinal and Hepatic Pharmacology

Shuyu Wang
Yuanlin Li
Xiaoqi Yang
Yinxue Hao
Xueyan Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359954

1,664 views

Review

Published on 29 Feb 2024

Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications

in Gastrointestinal and Hepatic Pharmacology

Yongkang Cheng
Sansan Feng
Chuqiao Sheng
Chunfeng Yang
Yumei Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1354809

4,046 views
4 citations

Original Research

Published on 23 Feb 2024

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

in Gastrointestinal and Hepatic Pharmacology

Yue Chen
Yutao Wang
Jin Lei
Bowen Chen
Xinfeng Zhang
Liangzheng Chang
Zhangli Hu
Yun Wang
Yinying Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1364924

1,618 views

Original Research

Published on 23 Feb 2024

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients

in Gastrointestinal and Hepatic Pharmacology

Jingwei Zhu
Zhe Wang
Xiaotong Sun
Dan Wang
Xinbo Xu
Liping Yang
Jiangdong Du
Zhimei Zhou
Yanhua Qi
Linfeng Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358262

1,258 views
1 citation

Navigation group

Articles

Protective effect of oxytocin on vincristine-induced gastrointestinal dysmotility in mice

Antibiotics influence the risk of anti-drug antibody formation during anti-TNF therapy in Chinese inflammatory bowel disease patients

Efficacy and safety of low-dose esketamine for painless gastrointestinal endoscopy in adults: a systematic evaluation and meta-analysis

Understanding the action mechanisms of metformin in the gastrointestinal tract

Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications

The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status

Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity

Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives

Integration of meta-analysis and network pharmacology analysis to investigate the pharmacological mechanisms of traditional Chinese medicine in the treatment of hepatocellular carcinoma

Corrigendum: Patchouli alcohol improved diarrhea-predominant irritable bowel syndrome by regulating excitatory neurotransmission in the myenteric plexus of rats

Effectiveness of prophylactic antibacterial drugs for patients with liver cirrhosis and upper gastrointestinal bleeding: a systematic review and meta-analysis

Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1

The effects of Massa Medicata Fermentata on the digestive function and intestinal flora of mice with functional dyspepsia

Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications

Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients